Overview
Portfolio
More
Vcgfsh.Org.Cn
Hong Kong SAR China
Growth capital private equity fund targeting fast‑growing fintech companies in China and the broader Asia‑Pacific region, with a focus on real‑world applications and underlying financial‑technology innovations.
Portfolio
9+
Employees
25+
Founded
2015
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Asia Pacific
Sources
Vcgfsh.Org.Cn
Growth capital private equity fund targeting fast‑growing fintech companies in China and the broader Asia‑Pacific region, with a focus on real‑world applications and underlying financial‑technology innovations.
Portfolio
9+
Employees
25+
Founded
2015
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
Asia Pacific
Sources
Showing 9 of 9 matched portfolio companies
Baca is an Indonesian content platform that aggregates up-to-date news, video clips, and humor in one mobile‑optimized site. It curates articles and media from multiple sources, organizes them into clear categories, and offers real‑time updates, search, and social sharing so users can stay informed and entertained without navigating separate websites.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
The startup develops targeted therapies for cancer treatment through drug discovery focused on tumor immunology. By enhancing the immune response against tumors, the company aims to improve the quality of life for cancer patients.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
IDVerse provides a fully automated identity verification solution that uses facial recognition and machine learning to authenticate users in real-time across 220 countries, achieving 99.99% accuracy. The platform addresses the challenges of identity fraud and compliance by enabling secure onboarding and KYC processes without human intervention.
Funding: $30.0M
Rough estimate of the amount of funding raised
Funding: $30.0M
Rough estimate of the amount of funding raised
LongRuan provides an integrated geospatial information system that combines 2D, 3D and 4D GIS with IoT, big‑data, cloud and AI to deliver real‑time visualization and analysis of geological, equipment, production and environmental data. Its TGIS platform offers a single‑map engine, mobile GIS clients and cloud services that enable safety monitoring, ventilation control, resource management and regulatory reporting for mining and large industrial operations.
The startup operates a molecular imaging platform that utilizes non-invasive radiopharmaceutical imaging technology to detect early-stage colorectal, esophageal, and lung adenocarcinoma. This technology enables healthcare providers to make precise diagnoses and tailor cancer treatment plans, improving patient outcomes and care efficiency.
10+
200+Approximate amount of employees
Funding: $2.5M
Rough estimate of the amount of funding raised
Funding: $2.5M
Rough estimate of the amount of funding raised
Where You At is a mobile application that allows users to locate friends in crowded venues without relying on cellular signal or internet connectivity, utilizing a proprietary mapping technology. The platform also provides venues with analytics and communication tools to enhance safety and compliance, improving the overall event experience.
Funding: $7.0M
Rough estimate of the amount of funding raised
Funding: $7.0M
Rough estimate of the amount of funding raised
Feisu provides a cloud-native low-code platform that enhances code efficiency for developers by streamlining the development process across various scenarios. This solution addresses the challenge of slow development cycles and high resource consumption in software projects.
XinpleTek develops high-performance RF front-end solutions for mobile communication and IoT devices, utilizing advanced RF component technology to enhance wireless connectivity. Their products address the need for efficient and reliable signal transmission in the rapidly growing 5G and IoT markets.
The startup develops TCR gene therapy solutions that provide personalized immunotherapy for cancer patients by engineering T-cell receptors to target specific tumor antigens. This approach enhances treatment efficacy and minimizes side effects compared to traditional therapies.